Infectious Disease Control
Fosun Foundation's Second Batch of More Than 500,000 Pieces of Anti-epidemic Materials Arrives in Hong Kong Successively to Aid High-risk Groups and Grassroots Families
HONG KONG, March 10, 2022 /PRNewswire/ -- In the face of the severe fifth wave of epidemic inHong Kong, Fosun Foundation quickly launched the epidemic relief work of "Let's Work Hand in Hand and Combat the Epidemic Together" inHong Kong. After the first batch of 250,000 sets of COVID-19 rapid ant...
2022-03-10 14:25
3962
Pudu Robotics Helps Hong Kong Combat Covid-19 Pandemic
The firm once again participates in the fight against the pandemic by donating
robots that support contactless delivery and automatic disinfection
SHENZHEN, China, March 9, 2022 /PRNewswire/ -- Pudu Robotics
2022-03-09 20:00
3391
China.org.cn: Hong Kong's fight against COVID-19: a test for "one country, two systems"
BEIJING, March 4, 2022 /PRNewswire/ -- A news report from China.org.cn on Hong Kong's COVID-19 pandemic situation:   Hong Kong has been taken aback by the 5th onset of the COVID-19 pandemic, and it's spreading fast.Hong Kong is a metropolis that runs under the "one country, two...
2022-03-04 22:00
4187
Scientific leaders signal major breakthroughs in elimination of cervical and anal cancers
GENEVA, March 4, 2022 /PRNewswire/ -- To mark International HPV Awareness Day
March 4th 2022, the International Papillomavirus Society (IPVS) has warmly
welcomed two major advances in the elimination of cervical and anal cancers.
2022-03-04 08:01
4283
Active agent in Australian-developed nasal spray >99.5% active against the Omicron SARS-CoV-2 variant
* The antiviral agent in VIRALEZE™ antiviral nasal spray, SPL7013, achieved >99.5% reduction of virus infectivity (the maximal possible reduction) against the highly contagious Omicron variant of SARS-CoV-2 * SPL7013 showed potent antiviral activity and was virucidal against the Omicron varia...
2022-03-01 16:44
2954
Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical Trial
- NVX-CoV2373 demonstrates protection against symptomatic and asymptomatic infection - High level of vaccine efficacy maintained over a 6-month period of surveillance - Continued reassuring safety profile in line with previous trials GAITHERSBURG, Md., March 1, 2022 /PRNewswire/ -- Novavax, In...
2022-03-01 05:01
4117
Lalamove delivers care in Hong Kong amid fifth wave of COVID-19
HONG KONG, Feb. 24, 2022 /PRNewswire/ -- Lalamove, a leading 24/7 on-demand delivery platform, has been paying close attention to the COVID-19 situation in Hong Kong. As the fifth wave of COVID-19 infections ravages the city, Lalamove launched a series of initiatives in February to help the commun...
2022-02-24 20:20
4221
Seegene unveils new assay optimized for on-site testing in 'living with Covid-19' era
SEOUL, South Korea, Feb. 24, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today, announced the CE-IVD marking of its Allplex™ SARS-CoV-2 fast MDx Assay. This new assay is optimized for the 'living with COVID-19' era, where mass, swift and ...
2022-02-24 20:00
2841
CanSinoBIO's Convidecia™ Approved as Heterologous Booster in China
TIANJIN, China, Feb. 21, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) ("Ad5-nCoV", trade name: Convidecia™) has been approved by the Joint Prevention and Control Mechanism ...
2022-02-21 08:05
3976
BioWorld by Clarivate Provides In-depth Analyses of Long COVID Studies, Potentially the Next Public Health Crisis
40-plus therapeutics in development even as researchers are trying to reach consensus on the syndrome LONDON, Feb. 17, 2022 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, has ann...
2022-02-17 16:00
3518
NIBIOHN, Shionogi Discover Host Immune-dependent Novel Anti-coronavirus Antibody
OSAKA, Japan, Feb. 16, 2022 /PRNewswire/ -- The National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN;Ibaraki-shi, Osaka; Director-general:Yoshihiro Yoneda), in partnership with Shionogi & Co., Ltd. (Chuo-ku,Osaka; President and CEO: Isao Teshirogi), has successfully identif...
2022-02-16 14:00
3606
HPG: New Breakthrough in Virus Inactivation with Green Tea Catechin (EGCg)
TOKYO, Feb. 15, 2022 /PRNewswire/ -- HPG Co., Ltd. (Chuo-ku, Tokyo) has successfully developed a water-soluble formulation technology of highly concentrated catechin EGCg (Epigallocatechin gallate) with excellent storage stability and initiated procedures for a patent application for the technolo...
2022-02-15 16:00
1829
Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine
Nuvaxovid™ is the first protein-based COVID-19 vaccine authorized for use in Singapore GAITHERSBURG, Md., Feb. 15, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, toda...
2022-02-15 05:02
2921
Shanghai Public Health Clinical Center Initiated Functional Cure Study of Anti-PD-L1 Antibody ASC22 (Envafolimab) in Combination With Chidamide in HIV-Infected Patients
HANGZHOU, China and SHAOXING, China, Feb. 14, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that Shanghai Public Health Clinical Center initiated functional cure study of anti-PD-L1 antibody ASC22 (Envafolimab) in combination with Chidamide in patients infected by human ...
2022-02-14 17:34
4665
Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial
- PREVENT-19 pediatric expansion in adolescents aged 12 through 17 achieved primary effectiveness endpoint demonstrating comparability to adult population - Trial demonstrated 82% clinical efficacy against Delta variant - Immune responses were about two-to-three-fold higher in adolescents than in...
2022-02-11 10:45
4889
Seegene Signs Supply Deal to Deliver 4 million COVID-19 Tests to Brazil
SEOUL, South Korea, Feb. 10, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostic company, today announced that it has signed a supply deal with the Ministry of Health ofBrazil to deliver four million COVID-19 tests. Since January 2022, Brazil has battled a...
2022-02-10 20:00
3028
Bactiguard presents focused growth strategy and sets new long-term financial targets
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- Bactiguard presents new long-term financial targets in connection with the year-end report for 2021. The new financial targets relate to growth and profitability, with annual revenues of at least1 billion SEK and annual EBITDA of at least 400 million SEK in...
2022-02-09 07:27
2609
mRNA COVID-19 Vaccines are Safe for People with Cancer According to New Study in JNCCN
Researchers at Fox Chase Cancer Center conducted the largest published, peer-reviewed, study to-date examining the short-term adverse effects of mRNA COVID-19 vaccination in patients with cancer—finding they experienced no more, and no different, side effects compared to non-cancer patients. PLY...
2022-02-08 05:11
2809
The one-component Sputnik Light vaccine has been authorized in India; over 2.5 billion people live in countries that approved Sputnik Light as a standalone vaccine and a universal booster
Sputnik Light will be an important part of India's vaccination program and the fight against mutations of COVID, including Omicron. Sputnik Light has been authorized in more than 30 countries with total population of over 2.5 billion people. MOSCOW, Feb. 7, 2022 /PRNewswire/ -- The Russian Dir...
2022-02-07 08:18
5226
New Zealand's Medsafe Grants Provisional Approval for Novavax' COVID-19 Vaccine
Nuvaxovid™ is the first protein-based COVID-19 vaccine to receive provisional approval for distribution inNew Zealand GAITHERSBURG, Md., Feb. 4, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for ser...
2022-02-04 06:54
3280
Week's Top Stories
Most Reposted
Sustainable Tourism Academy Celebrates 3,000-User Milestone in First Year with ASEAN Expansion and New Language Support
[Picked up by 322 media titles]
2026-06-29 12:41
MetaOptics Begins Shipment of Metalens Smartphone and AI Smart Glasses to European and Japanese Customers for Evaluation
[Picked up by 302 media titles]
2026-06-26 18:11Vietnam Explores Sustainable Aviation Fuel Development at International Conference in Hanoi
[Picked up by 301 media titles]
2026-06-25 14:33
SPHERE AX Partners with U.S. AI Semiconductor Company Blaize at the National Assembly
[Picked up by 293 media titles]
2026-06-24 18:00
BELLUSTAR TOKYO Ranked No. 10 Among Japan's Best City Hotels in Prestigious Award Chosen by Asia-Pacific Travelers
[Picked up by 290 media titles]
2026-06-24 12:00
Most Read
Korean Skincare Brand Meditherapy Tops Amazon U.S. Facial Serums, Breaking Into Beauty Best Sellers Top 20
2026-06-26 21:00
3888
Farmmi, Inc. Announces Launch of Proposed Public Offering
2026-06-27 08:01
3776
National Book Store Partners with Anchanto to accelerate success across Online Channels & 260+ Retail Locations
2026-06-23 08:00
3532
